Parkinson's Update 2023: News from research, diagnostics and therapy - online press conference on March 13, 2023

Parkinson's research is making great progress - new therapeutic and diagnostic approaches give reason for hope. The incurable nerve disease is now symptomatically well treatable. However, the current research also sheds new light on the individual causes and on new opportunities for early diagnosis with the aim of developing the first causal therapy. Two years ago, the German Society for Parkinson's and Movement Disorders (DPG) launched the "Parkinson Agenda 2030" and considers this goal to be realistic from a professional point of view - provided that Parkinson's research is publicly funded and structured more stringently in the future. "Due to the enormous increase in knowledge in recent years, not only the precise phenotyping of individual movement disorders is possible today. New technologies such as sensors and innovative imaging methods also offer promising opportunities to individualize the treatment of those affected and thus further improve it," says Prof. Alexander Storch, DPG Congress President and 2nd Chairman of the DPG.

Am Monday, March 13, 2023, from 10 a.m. to 11 a.m., invites the German Society for Parkinson's and Movement Disorders (DPG) to an online press conference. Journalists from the specialist and popular media have the opportunity to discuss news from therapy, diagnostics and care with experts. The occasion is "Parkinson and Movement Disorders - Highlights Digital 2023", the virtual specialist event of the DPG on March 16th and 17th, 2023.

Journalist accreditation for the press conference here
Journalist accreditation for Highlights Digital 2023 at www.dpg-akbont-kongress.de

Program of the press conference (Changes reserved)

Parkinson's Agenda 2030: when will the breakthrough in Parkinson's research come?
Prof. Dr. Joseph Classen, 1st Chairman of the DPG, Director of the Clinic and Polyclinic for Neurology at the University Hospital Leipzig

Technology-enhanced treatment strategies - current practice and future perspectives
Prof. Dr. alexander stork, 2nd Chairman of the DPG and Congress President "Highlights Digital 2023", Director of the Clinic and Polyclinic for Neurology University Medicine Rostock

Parkinson's diagnosis: biomarkers and genes - new opportunities and challenges
PD dr Catherine Brockmann, 3. Chairwoman of the DPG, senior physician and head of the Parkinson's outpatient clinic at the University Hospital in Tübingen

Cure in sight? Advances towards causal therapy
Prof. Dr. Uwe Walter, Deputy director of the clinic and polyclinic for neurology at the University Medicine Rostock

DPG press office c/o albert ZWEI media GmbH
Dipl.-Biol. Sandra Wilcken, phone: +49 (0) 89 46148611; E-mail: presse@parkinson-gesellschaft.de

Journalists can register at www.dpg-akbont-kongress.de also register free of charge for virtual participation in Highlights Digital 2023. You will have access to the recordings of the meetings after the congress. Current press releases and information on the topics of the online press conference on March 13, 2023 can be found at www.parkinson-gesellschaft.de/presse. We would be happy to support you with your reporting, provide experts and images. We look forward to hearing about your publication or sending you a copy.